25 research outputs found
âPrimus inter Paresâ?âThe Perception of Emergent Leadership Behavior in Agile Software Development Teams
Despite being a key feature of Agile Software Development (ASD), self-organization within ASD teams has received limited research attention. Hence, this study furthers our understanding of how informal emergent leadership may develop within ASD teams by combining knowledge on ASD teams with extant research on emergent leadership. In an exploratory mixed-method study of two Scrum teams, we observed two specific types of emergent leaders, namely, a âdetail-oriented structurerâ, and a âbig picture coordinator.â For emergent leadership to develop, the Scrum master had to create a âleadership gap.â Given this leadership gap, emergent leadership may develop in a circular manner: specific behaviors of team members and their perceptions may provide the basis for emergent leadership, which combined with implicit leadership theories of team members give rise to a leadership structure. Our results add to research on emergent leadership and increase our understanding of self-organization in ASD teams
Exploring Capabilities for the Smart Service Transformation in Manufacturing: Insights from Theory and Practice
Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study
Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ℠0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe
Towards the Next Decade of Industrie 4.0 â Current State in Research and Adoption and Promising Development Paths from a German Perspective
Considering the first ten years of Industrie 4.0 in Germanyâthe digital transformation of industry towards the goal of increased manufacturing productivity and mass customizationâsignificant progress has been achieved. However, future efforts are required. This review first evaluates the status quo of implementation and research in Germany and finds that large-scale companies have proceeded faster than small- and middle-sized enterprises. Currently, regardless of their size, companies have in common a shortage of qualified specialists, coupled with a lack of adequate base technologies for Industrie 4.0 and an insufficient digital mindset. The creation of platform-based digital business models is particularly lagging behind, despite high research interest. This review subsequently identifies three research-driven fields of action that are particularly important for the future of Industrie 4.0: (1) resilience of value networks in the strategic area of sovereignty, (2) Open-Source as a driver for the strategic area of interoperability, and (3) the strategic combination of digitalization and sustainability as a basis for sustainable business models in the strategic area of sustainability
Digitainability : digitale SchlĂŒsseltechnologien fĂŒr ökologisch nachhaltiges Wirtschaften: Marktpotenziale und strategische Implikationen
Risk factors for long-term invasive mechanical ventilation: a longitudinal study using German health claims data
Abstract Background Long-term invasive mechanical ventilation (IMV) is a major burden for those affected and causes high costs for the health care system. Early risk assessment is a prerequisite for the best possible support of high-risk patients during the weaning process. We aimed to identify risk factors for long-term IMV within 96 h (h) after the onset of IMV. Methods The analysis was based on data from one of Germany's largest statutory health insurance funds; patients who received IMVââ„â96 h and were admitted in January 2015 at the earliest and discharged in December 2017 at the latest were analysed. OPS and ICD codes of IMV patients were considered, including the 365 days before intubation and 30 days after discharge. Long-term IMV was defined as evidence of invasive home mechanical ventilation (HMV), IMVââ„â500 h, or readmission with (re)prolonged ventilation. Results In the analysis of 7758 hospitalisations, criteria for long-term IMV were met in 38.3% of cases, of which 13.9% had evidence of HMV, 73.1% received IMVââ„â500 h and/or 40.3% were re-hospitalised with IMV. Several independent risk factors were identified (pâ<â0.005 each), including pre-diagnoses such as pneumothorax (OR 2.10), acute pancreatitis (OR 2.64), eating disorders (OR 1.99) or rheumatic mitral valve disease (OR 1.89). Among ICU admissions, previous dependence on an aspirator or respirator (OR 5.13), and previous tracheostomy (OR 2.17) were particularly important, while neurosurgery (OR 2.61), early tracheostomy (OR 3.97) and treatment for severe respiratory failure such as positioning treatment (OR 2.31) and extracorporeal lung support (OR 1.80) were relevant procedures in the first 96 h after intubation. Conclusion This comprehensive analysis of health claims has identified several risk factors for the risk of long-term ventilation. In addition to the known clinical risks, the information obtained may help to identify patients at risk at an early stage. Trial registration The PRiVENT study was retrospectively registered at ClinicalTrials.gov (NCT05260853). Registered at March 2, 2022
Immunocompromised patients with acute respiratory distress syndrome : Secondary analysis of the LUNG SAFE database
The aim of this study was to describe data on epidemiology, ventilatory management, and outcome of acute respiratory distress syndrome (ARDS) in immunocompromised patients. Methods: We performed a post hoc analysis on the cohort of immunocompromised patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study. The LUNG SAFE study was an international, prospective study including hypoxemic patients in 459 ICUs from 50 countries across 5 continents. Results: Of 2813 patients with ARDS, 584 (20.8%) were immunocompromised, 38.9% of whom had an unspecified cause. Pneumonia, nonpulmonary sepsis, and noncardiogenic shock were their most common risk factors for ARDS. Hospital mortality was higher in immunocompromised than in immunocompetent patients (52.4% vs 36.2%; p < 0.0001), despite similar severity of ARDS. Decisions regarding limiting life-sustaining measures were significantly more frequent in immunocompromised patients (27.1% vs 18.6%; p < 0.0001). Use of noninvasive ventilation (NIV) as first-line treatment was higher in immunocompromised patients (20.9% vs 15.9%; p = 0.0048), and immunodeficiency remained independently associated with the use of NIV after adjustment for confounders. Forty-eight percent of the patients treated with NIV were intubated, and their mortality was not different from that of the patients invasively ventilated ab initio. Conclusions: Immunosuppression is frequent in patients with ARDS, and infections are the main risk factors for ARDS in these immunocompromised patients. Their management differs from that of immunocompetent patients, particularly the greater use of NIV as first-line ventilation strategy. Compared with immunocompetent subjects, they have higher mortality regardless of ARDS severity as well as a higher frequency of limitation of life-sustaining measures. Nonetheless, nearly half of these patients survive to hospital discharge. Trial registration: ClinicalTrials.gov, NCT02010073. Registered on 12 December 2013
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and outcome of acute respiratory distress syndrome (ARDS) in immunocompromised patients. Methods: We performed a post hoc analysis on the cohort of immunocompromised patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study. The LUNG SAFE study was an international, prospective study including hypoxemic patients in 459 ICUs from 50 countries across 5 continents. Results: Of 2813 patients with ARDS, 584 (20.8%) were immunocompromised, 38.9% of whom had an unspecified cause. Pneumonia, nonpulmonary sepsis, and noncardiogenic shock were their most common risk factors for ARDS. Hospital mortality was higher in immunocompromised than in immunocompetent patients (52.4% vs 36.2%; p < 0.0001), despite similar severity of ARDS. Decisions regarding limiting life-sustaining measures were significantly more frequent in immunocompromised patients (27.1% vs 18.6%; p < 0.0001). Use of noninvasive ventilation (NIV) as first-line treatment was higher in immunocompromised patients (20.9% vs 15.9%; p = 0.0048), and immunodeficiency remained independently associated with the use of NIV after adjustment for confounders. Forty-eight percent of the patients treated with NIV were intubated, and their mortality was not different from that of the patients invasively ventilated ab initio. Conclusions: Immunosuppression is frequent in patients with ARDS, and infections are the main risk factors for ARDS in these immunocompromised patients. Their management differs from that of immunocompetent patients, particularly the greater use of NIV as first-line ventilation strategy. Compared with immunocompetent subjects, they have higher mortality regardless of ARDS severity as well as a higher frequency of limitation of life-sustaining measures. Nonetheless, nearly half of these patients survive to hospital discharge. Trial registration: ClinicalTrials.gov, NCT02010073. Registered on 12 December 2013
Reduced order modeling for cardiac electrophysiology and mechanics: New methodologies, challenges and perspectives
Reduced-order modeling techniques enable a remarkable speed up in the solution of the parametrized electromechanical model for heart dynamics. Being able to rapidly approximate the solution of this problem allows to investigate the impact of significant model parameters querying the parameter-to-solution map in a very inexpensive way. The construction of reduced-order approximations for cardiac electromechanics faces several challenges from both modeling and computational viewpoints, because of the multiscale nature of the problem, the need of coupling different physics, and the nonlinearities involved. Our approach relies on the reduced basis method for parametrized PDEs. This technique performs a Galerkin projection onto low-dimensional spaces built from a set of snapshots of the high-fidelity problem by the Proper Orthogonal Decomposition technique. Snapshots are obtained for different values of the parameters and computed, e.g., by the finite element method. Then, suitable hyper-reduction techniques, in particular the Discrete Empirical Interpolation Method and its matrix version, are called into play to efficiently handle nonlinear and parameter-dependent terms. In this work we show how a fast and reliable approximation of both the electrical and the mechanical model can be achieved by developing two separate reduced order models where the interaction of the cardiac electrophysiology system with the contractile muscle tissue, as well as the sub-cellular activation-contraction mechanism, are included. Open challenges and possible perspectives are finally outlined